Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
7 results loaded, newest first. End of these results.
The company reported results for the period ended 31 May 2026 and said CEO Jerry Randall intends to retire from the role. It also highlighted revenue growth, a share buyback programme and recent disposals and acquisitions.
Henry Schein (NASDAQ: HSIC ) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Henry Schein Inc reported strong financial performance in the se
B2Gold (TSX: BTO ) held its second-quarter earnings conference call on Friday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary B2Gold Corporation reported consolidated gold production of appro
B2Gold (AMEX: BTG ) reported second-quarter financial results on Friday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. The full earnings call is available at Summary B2Gold Corpo
Cisco, SpaceX, Cerebras, Infleqtion and Coherent were active in trading after Cisco, Cerebras, Infleqtion and Coherent reported quarterly results, while SpaceX disclosed Starlink subscriber growth.
Health care giant Johnson & Johnson (NYSE: JNJ ) reports second-quarter financial results on Wednesday before the market opens. Here are the earnings estimates, what experts are saying and key items to watch. Johnson & Johnson Q2 Earnings Estimates Analysts expect Johnson & Johnson to report second-quarter revenue of $
Johnson & Johnson (NYSE: JNJ ) will release its second-quarter earnings report before the opening bell on Wednesday, July 15. Analysts expect the company to report quarterly earnings of $2.85 per share, up from $2.77 per share in the year-ago period. The consensus estimate for Johnson & Johnson’s quarterly revenue is $